Psy Therapeutics is Drug Discovery in United States that focus on major depressive disorder business. Founded in 2012. They cover business area such as developer, therapeutic drug, high potential central nervous system disease, research strategy, prove drug target, innovative screening platform, target champion, flexible use, r&d tool, healthcare professional, technology, treatment, anxiety disorder, major depressive disorder, dementia.
2012
( 12 years old in 2024 )
Major Depressive Disorder
-
28 Atlantic Avenue
Suite 129
Boston, MA 02110
United States
Private
developertherapeutic drughigh potential central nervous system diseaseresearch strategyprove drug targetinnovative screening platformtarget championflexible user&d toolhealthcare professionaltechnologytreatmentanxiety disordermajor depressive disorderdementia
* We use standard office opening hours in near Psy Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Psy Therapeutics is Drug Discovery business from United States that founded in 2012 (12 years old in 2024), Psy Therapeutics business is focusing on Major Depressive Disorder.
Psy Therapeutics headquarter office and corporate office address is located in 28 Atlantic Avenue Suite 129 Boston, MA 02110 United States.
Psy Therapeutics was founded in United States.
In 2024, Psy Therapeutics is currently focus on major depressive disorder sector.
Above is snippet of Google Trends for "major depressive disorder" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Psy Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
